Plain-English translation of NCT05546099 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new way to help people with chronic kidney disease control their blood pressure. Instead of only seeing a doctor to adjust medications, you would work directly with a clinical pharmacist to manage and adjust your blood pressure medicines at home based on your own blood pressure readings. The goal is to help more patients reach healthy blood pressure levels and protect their kidneys and heart.
Many people with kidney disease struggle to get their blood pressure under control even though many medications are available. This trial exists to see if giving patients more control—with a pharmacist's guidance—can help them reach their blood pressure goals and prevent complications like heart disease and further kidney damage.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to one of two groups. In the self-management group, you would check your blood pressure at home regularly and adjust your own medications following a plan created with a clinical pharmacist—the pharmacist guides you through this process. In the comparison group, you would monitor your blood pressure at home but contact your doctor if it stays too high. Either way, you would work closely with the research team to track how well the approach works for managing your blood pressure.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States